Skip to content
Screener

Rapid Micro Biosystems RPID Q1 2026 earnings

Reported May 13, 2026 · Before market open

Revenue$8.0MBeat by $402.0K
EPS-$0.31Miss by $0.06
Revenue estimate$7.6M
EPS estimate-$0.25

Next report

Nov 6, 2026 (in 2 months)
Revenue estimate$10.0M
EPS estimate-$0.19

Financials

Q1 2026

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$103.2M-9.6%
Enterprise value$112.87M+12.0%
P/S3×-0.8×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Segments

By product

See full
Service$2.4M-21.9%

FAQ

When did Rapid Micro Biosystems report Q1 2026 earnings?
Rapid Micro Biosystems (RPID) reported Q1 2026 earnings on May 13, 2026 before market open.
What were Rapid Micro Biosystems's Q1 2026 revenue and EPS?
Rapid Micro Biosystems reported revenue of $8.0M and eps of $-0.31 for Q1 2026.
Did Rapid Micro Biosystems beat estimates in Q1 2026?
Revenue beat the consensus estimate of $7.6M by $402.0K. EPS missed the consensus estimate of $-0.25 by $0.06.
How did Rapid Micro Biosystems's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 11.1% from $7.2M a year earlier and eps declined 19.2% from $-0.26.
Where can I find Rapid Micro Biosystems's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001380106-26-000067) and the 10-Q periodic report (0001380106-26-000075) directly on SEC EDGAR. The filing index links above go to sec.gov.